Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-01-30

Clinical Trial Update: Iodinated Contrast Agents and Risk of Hypothyroidism in Young Children in the United States

View source ↗

Summary

A Bayer-sponsored trial evaluated whether iodinated contrast agents used in imaging increase the risk of hypothyroidism in young children. The results were post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Iodinated contrast agents (iodinated contrast agents)

Snippet

Sponsor: Bayer | Conditions: Hypothyroidism | Status: COMPLETED | Results posted: 2019-01-30